Procter & Gamble Company (The)

As of June 30, 2026, Procter & Gamble Company Shs Sponsored canadian Depositary Receipt Repr Sh carries a market capitalization of 480.27B, placing it among publicly traded companies globally. Its enterprise value stands at 517.27B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Procter & Gamble Company Shs Sponsored canadian Depositary Receipt Repr Sh's next confirmed earnings release is scheduled for January 20, 2027.

As of June 30, 2026, Procter & Gamble Company Shs Sponsored canadian Depositary Receipt Repr Sh has 19.87B shares outstanding.

As of June 30, 2026, Procter & Gamble Company Shs Sponsored canadian Depositary Receipt Repr Sh trades at a trailing price-to-earnings ratio of 21.94. The price-to-sales ratio is 3.97, and the price-to-book ratio stands at 6.35.

As of June 30, 2026, Procter & Gamble Company Shs Sponsored canadian Depositary Receipt Repr Sh trades at an EV/EBITDA multiple of 15.91 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 4.19 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 18.46 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Procter & Gamble Company Shs Sponsored canadian Depositary Receipt Repr Sh trades at an EV/FCF ratio of 18.00, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 517.27B versus a market cap of 480.27B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Procter & Gamble Company Shs Sponsored canadian Depositary Receipt Repr Sh maintains a current ratio of 0.68, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 64.49, indicating elevated leverage, while an interest coverage ratio of 26.15 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Procter & Gamble Company Shs Sponsored canadian Depositary Receipt Repr Sh posted a return on equity (ROE) of 30.13, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 17.48 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 12.75, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 18.79, useful for judging operating efficiency across full business cycles. The company generates approximately 1.15M in revenue per employee across its workforce of 107,750.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 5.52 indicates how many times Procter & Gamble Company Shs Sponsored canadian Depositary Receipt Repr Sh sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Procter & Gamble Company Shs Sponsored canadian Depositary Receipt Repr Sh recorded 6.01B in income tax expense. That works out to an effective tax rate of 20.78, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 28.92B, leaving 22.77B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Procter & Gamble Company Shs Sponsored canadian Depositary Receipt Repr Sh's stock has gained approximately 6.90% over the past 52 weeks. The 50-day moving average sits at 24.31, while the 200-day moving average is 24.55.

Over the twelve months ended June 30, 2026, Procter & Gamble Company Shs Sponsored canadian Depositary Receipt Repr Sh generated 123.52B in revenue and converted that into 22.77B in net income, yielding earnings per share of 1.11. EBITDA reached 32.51B, while operating income came in at 28.03B.

As of June 30, 2026, Procter & Gamble Company Shs Sponsored canadian Depositary Receipt Repr Sh holds 14.11B in cash and equivalents against 49.71B in total debt, resulting in a net debt position of 34.34B. Total book value stands at 75.68B, with working capital of -17.72B providing operational flexibility.

Procter & Gamble Company Shs Sponsored canadian Depositary Receipt Repr Sh produced 27.75B in operating cash flow over the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Procter & Gamble Company Shs Sponsored canadian Depositary Receipt Repr Sh posted a gross margin of 50.18, reflecting its pricing power and cost economics. The operating margin of 22.69 and net profit margin of 18.44 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Procter & Gamble Company Shs Sponsored canadian Depositary Receipt Repr Sh paid dividends of 0.72 per share. The dividend payout ratio of 62.32 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 5.54, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 4.27, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Procter & Gamble Company Shs Sponsored canadian Depositary Receipt Repr Sh shareholders.

As of June 30, 2026, Procter & Gamble Company Shs Sponsored canadian Depositary Receipt Repr Sh has an Altman Z-Score of 7.94, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.